The International Society of Urological Pathology Consultation on Molecular Pathology of Urogenital Cancer.
Journal
The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
pubmed:
29
4
2020
medline:
22
10
2020
entrez:
29
4
2020
Statut:
ppublish
Résumé
The 2019 Consultation Conference on the molecular pathology of urogenital cancers was organized by the International Society of Urological Pathology (ISUP) to have an understanding of the current use of molecular-genetic markers and to make recommendations on their application in prostate, bladder, renal, testicular, and penile cancer. This brief introductory article describes the organization of this conference and provides its rationale and main findings.
Identifiants
pubmed: 32341239
doi: 10.1097/PAS.0000000000001496
pii: 00000478-202007000-00006
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Introductory Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
859-861Références
Creighton CJ. The clinical applications of The Cancer Genome Atlas project for bladder cancer. Expert Rev Anticancer Ther. 2018;18:973–980.
Wedge DC, Gundem G, Mitchell T, et al. Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. Nat Genet. 2018;50:682–692.
Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol. 2013;37:1469–1489.
Kujtan L, Hussain A, Subramanian J, et al. The evolving genomic landscape in urothelial cancer. Curr Opin Oncol. 2018;30:197–202.
Berney DM, Looijenga LH, Idrees M, et al. Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy. Histopathology. 2016;69:7–10.
Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001;159:1211–1218.
Lotan TL, Tomlins SA, Bismar TA, et al. Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer. Am J Surg Pathol. 2020. [Epub ahead of print].
Warrick JI, Knowles MA, Allory Y, et al. Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: progress and challenges. Am J Surg Pathol. 2020. [Epub ahead of print].
Williamson SR, Gill AJ, Argani P, et al. Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. The International Society of Urological Pathology Consensus on III. Molecular Pathology of Kidney Cancer. Am J Surg Pathol. 2020. [Epub ahead of print].
Looijenga LHJ, Van der Kwast TH, Grignon D, et al. Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: current and future utilization of molecular-genetic tests for testicular germ cell tumors. Am J Surg Pathol. 2020. [Epub ahead of print].
Canete-Portillo S, Velasques EF, Kristiansen G, et al. Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology Of Urogenital Cancers.International Society of Urological Pathology (ISUP) Survey and V. Recommendations on on the Use of Immunohistochemical and/ Molecular Biomarkers in Penile Cancer. Am J Surg Pathol. 2020. [Epub ahead of print].
Carlo MI, Hakimi AA, Stewart GD, et al. Familial kidney cancer: implications of new syndromes and molecular insights. Eur Urol. 2019;76:754–764.
Amin MB, Trpkov K, Lopez-Beltran A, et al. Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38:e20–e34.
Ulbright TM, Tickoo SK, Berney DM, et al. Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the International Society of Urological Pathology consensus conference. Am J Surg Pathol. 2014;38:e50–e59.
Mohler JL, Antonarakis ES. NCCN guidelines updates: management of prostate cancer. J Natl Compr Canc Netw. 2019;17:583–586.
Mottet N, Bellmunt J, Briers E, et al. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Arnhem, The Netherlands: EAU Guidelines Office; 2020.
Eggener SE, Rumble RB, Armstrong AJ, et al. Molecular biomarkers in localized prostate cancer: ASCO Guideline. J Clin Oncol. 2020. [Epub ahead of print].
Sand FL, Rasmussen CL, Frederiksen MH, et al. Prognostic significance of HPV and p16 status in men diagnosed with penile cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2018;27:1123–1132.
Batista da Costa J, Gibb EA, Bivalacqua TJ, et al. Molecular characterization of neuroendocrine-like bladder cancer. Clin Cancer Res. 2019;25:3908–3920.
Motzer RJ, Jonasch E, Agarwal N, et al. National comprehensive cancer network. Kidney cancer, version 3.2015. J Natl Compr Canc Netw. 2015;13:151–159.